Dolby Laboratories, Inc. (DLB)
NYSE: DLB · Real-Time Price · USD
55.33
+0.56 (1.02%)
Nov 20, 2026, 4:00 PM EST - Market closed
Dolby Laboratories Revenue
In the fiscal year ending September 25, 2026, Dolby Laboratories had annual revenue of $1.42B with 5.32% growth. Dolby Laboratories had revenue of $373.54M in the quarter ending September 25, 2026, with 21.66% growth. That makes Dolby Laboratories the 6,223rd largest company in the world by revenue and 1,557th in the United States.
Revenue (ttm)
$1.42B
Revenue Growth
+5.32%
P/S Ratio
3.61
Revenue / Employee
$710,434
Employees
2,000
Market Cap
5.13B
Revenue by Segment
Fiscal year ended Sep 25, 2026 See the full Dolby Laboratories breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 25, 2026 | 1.42B | 71.74M | 5.32% |
| Sep 26, 2025 | 1.35B | 75.41M | 5.92% |
| Sep 27, 2024 | 1.27B | -26.02M | -2.00% |
| Sep 29, 2023 | 1.30B | 45.95M | 3.66% |
| Sep 30, 2022 | 1.25B | -27.46M | -2.14% |
| Sep 24, 2021 | 1.28B | 119.46M | 10.28% |
| Sep 25, 2020 | 1.16B | -79.83M | -6.43% |
| Sep 27, 2019 | 1.24B | 187.02M | 17.73% |
| Sep 28, 2018 | 1.05B | -25.58M | -2.37% |
| Sep 29, 2017 | 1.08B | 54.44M | 5.31% |
| Sep 30, 2016 | 1.03B | 55.10M | 5.68% |
| Sep 25, 2015 | 970.64M | 10.46M | 1.09% |
| Sep 26, 2014 | 960.18M | 50.50M | 5.55% |
| Sep 27, 2013 | 909.67M | -23.34M | -2.50% |
| Sep 28, 2012 | 933.01M | -28.05M | -2.92% |
| Sep 30, 2011 | 961.07M | 38.35M | 4.16% |
| Sep 24, 2010 | 922.71M | 203.21M | 28.24% |
| Sep 25, 2009 | 719.50M | 79.27M | 12.38% |
| Sep 26, 2008 | 640.23M | 158.20M | 32.82% |
| Sep 28, 2007 | 482.03M | 90.49M | 23.11% |
| Sep 29, 2006 | 391.54M | 63.58M | 19.38% |
| Sep 30, 2005 | 327.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aramark | 20.09B |
| ABM Industries | 9.15B |
| Rentokil Initial | 7.13B |
| Maximus | 5.23B |
| RB Global | 5.03B |
| Cimpress | 3.81B |
| UL Solutions | 3.19B |
| UniFirst | 2.52B |
DLB News
- 3 days ago - Dolby price target lowered to $60 from $62 at Baird - TheFly
- 3 days ago - Dolby price target lowered to $80 from $90 at Barrington - TheFly
- 3 days ago - Dolby price target lowered to $75 from $80 at Rosenblatt - TheFly
- 4 days ago - Dolby Laboratories Earnings Call Transcript: Q4 2026 - Transcripts
- 4 days ago - Dolby Laboratories Earnings release: Q4 2026 - Filings
- 4 days ago - Dolby Laboratories Slides: Q4 2026 - Filings
- 4 days ago - Dolby Laboratories Annual report: Q4 2026 - Filings
- 4 days ago - Dolby reports Q4 adjusted EPS $1.25, consensus $1.20 - TheFly